Calliditas Therapeutics AB (CALT)
20.64
+0.51
(+2.53%)
USD |
NASDAQ |
May 07, 16:00
Calliditas Therapeutics Market Cap: 553.90M for May 7, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 07, 2024 | 553.90M |
| May 06, 2024 | 540.21M |
| May 03, 2024 | 536.72M |
| May 02, 2024 | 509.94M |
| May 01, 2024 | 535.11M |
| April 30, 2024 | 535.11M |
| April 29, 2024 | 500.57M |
| April 26, 2024 | 523.32M |
| April 25, 2024 | 521.96M |
| April 24, 2024 | 496.47M |
| April 23, 2024 | 488.42M |
| April 22, 2024 | 485.26M |
| April 19, 2024 | 501.83M |
| April 18, 2024 | 473.66M |
| April 17, 2024 | 502.91M |
| April 16, 2024 | 477.66M |
| April 15, 2024 | 508.54M |
| April 12, 2024 | 509.88M |
| April 11, 2024 | 550.94M |
| April 10, 2024 | 577.51M |
| April 09, 2024 | 603.81M |
| April 08, 2024 | 577.24M |
| April 05, 2024 | 580.46M |
| April 04, 2024 | 592.54M |
| April 03, 2024 | 570.26M |
| Date | Value |
|---|---|
| April 02, 2024 | 570.26M |
| April 01, 2024 | 563.56M |
| March 28, 2024 | 563.82M |
| March 27, 2024 | 576.62M |
| March 26, 2024 | 586.37M |
| March 25, 2024 | 586.10M |
| March 22, 2024 | 570.27M |
| March 21, 2024 | 584.89M |
| March 20, 2024 | 571.61M |
| March 19, 2024 | 563.56M |
| March 18, 2024 | 591.73M |
| March 15, 2024 | 598.44M |
| March 14, 2024 | 602.47M |
| March 13, 2024 | 622.06M |
| March 12, 2024 | 592.27M |
| March 11, 2024 | 597.10M |
| March 08, 2024 | 593.08M |
| March 07, 2024 | 620.72M |
| March 06, 2024 | 595.49M |
| March 05, 2024 | 548.93M |
| March 04, 2024 | 566.24M |
| March 01, 2024 | 575.10M |
| February 29, 2024 | 572.13M |
| February 28, 2024 | 587.17M |
| February 27, 2024 | 592.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
306.19M
Minimum
Oct 20 2022
915.18M
Maximum
Nov 30 2020
568.28M
Average
550.81M
Median
Jul 14 2020
Market Cap Benchmarks
| DBV Technologies SA | 127.60M |
| Cellectis SA | 223.78M |
| Adaptimmune Therapeutics PLC | 280.15M |
| Akari Therapeutics PLC | 11.41M |
| Biodexa Pharmaceuticals Plc | 4.473M |
Market Cap Related Metrics
| PS Ratio | 4.076 |
| Price to Book Value | 16.65 |
| Price | 20.64 |
| Earnings Yield | -4.76% |